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Abstract
Dengue hemorrhagic fever and/or dengue shock syndrome represent the most serious pathophysiological manifestations
of human dengue virus infection. Despite intensive research, the mechanisms and important cellular players that contribute
to dengue disease are unclear. Mast cells are tissue-resident innate immune cells that play a sentinel cell role in host
protection against infectious agents via pathogen-recognition receptors by producing potent mediators that modulate
inflammation, cell recruitment and normal vascular homeostasis. Most importantly, mast cells are susceptible to antibody-
enhanced dengue virus infection and respond with selective cytokine and chemokine responses. In order to obtain a global
view of dengue virus-induced gene regulation in mast cells, primary human cord blood-derived mast cells (CBMCs) and the
KU812 and HMC-1 mast cell lines were infected with dengue virus in the presence of dengue-immune sera and their
responses were evaluated at the mRNA and protein levels. Mast cells responded to antibody-enhanced dengue virus
infection or polyinosinic ˙polycytidylic acid treatment with the production of type I interferons and the rapid and potent
production of chemokines including CCL4, CCL5 and CXCL10. Multiple interferon-stimulated genes were also upregulated
as well as mRNA and protein for the RNA sensors PKR, RIG-I and MDA5. Dengue virus-induced chemokine production by
KU812 cells was significantly modulated by siRNA knockdown of RIG-I and PKR, in a negative and positive manner,
respectively. Pretreatment of fresh KU812 cells with supernatants from dengue virus-infected mast cells provided protection
from subsequent infection with dengue virus in a type I interferon-dependent manner. These findings support a role for
tissue-resident mast cells in the early detection of antibody-enhanced dengue virus infection via RNA sensors, the
protection of neighbouring cells through interferon production and the potential recruitment of leukocytes via chemokine
production.
Citation: Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, et al. (2012) RNA Sensors Enable Human Mast Cell Anti-Viral Chemokine Production and IFN-
Mediated Protection in Response to Antibody-Enhanced Dengue Virus Infection. PLoS ONE 7(3): e34055. doi:10.1371/journal.pone.0034055
Editor: Kui Li, University of Tennessee Health Science Center, United States of America
Received August 15, 2011; Accepted February 24, 2012; Published March 30, 2012
Copyright:  2012 Brown et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants MOP79419 and MOP10966 from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: robert.anderson@dal.ca
. These authors contributed equally to this work.
" These authors also contributed equally to this work.
Introduction
Mast cells are well known for their classical role in inflammation
and allergy but recent evidence has highlighted that their immune
functionshavemuchbroaderreachingimplications[1,2,3,4,5,6,7,8].
Studies suggest they also play an important sentinel cell role in host
defence, with the capacity to specifically respond to various types of
pathogens, including bacteria, fungi and viruses. Mast cells are
abundant at mucosal sites and skin, placing them in an opportune
location for interaction with invading pathogens.
Our studies involving mast cell responses to antibody-enhanced
dengue virus infection have highlighted potent immunoregulatory
activities of these cells, including secretion of tumor necrosis factor
[9] and the chemokines CC chemokine ligand (CCL)3, CCL4 and
CCL5 [10,11]. These studies, in addition to other published
reports [4,6,12,13], reinforce the role of mast cells as innate
immune effectors in response to virus infection. Furthermore,
these studies provide insight into the diversity of signals generated
in response to active virus infection or viral components, which
can influence the mode/action of antiviral activity. Chemokines
such as CCL3, CCL4 and CCL5 are important for the trafficking
of leukocytes such as monocytes, T cells, and natural killer (NK)
cells, all of which are suggested to play important roles in dengue
infection. While the influence of CCL4 and CCL5 on the overall
immune response to dengue virus infection is not well studied,
clinically these chemokines are decreased in serum of dengue
hemorrhagic fever patients, and therefore their levels may serve as
good prognostic factors for disease outcome [14,15].
Mast cells possess a complement of pattern recognition
receptors that vary according to the host source and associated
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34055tissue or organ [12,13,16,17,18,19,20]. Human mast cells express
the RNA sensor, Toll-like receptor (TLR)3 [13]. Recognition of
viral dsRNA by mast cell TLR3 leads to signaling via TRIF to
TBK1/IKKe to activate both interferon regulatory factor (IRF)3
and nuclear factor-kB (NF-kB) promoting the production of
interferon stimulated genes, cytokines and chemokines. In the case
of human mast cell line (HMC)-1, Laboratory of Allergic Diseases
(LAD)-2 and primary CD34
+ peripheral blood cell-derived mast
cells, responses to extracellular polyinosinic ˙polycytidylic acid
(polyI:C) were shown to involve upregulation of type I interferons
(IFNs) by RT-PCR [13]. Mast cells activated by polyI:C have also
been reported to influence CD8
+ T cell recruitment [12].
Furthermore, we have determined that polyI:C-exposed or
reovirus-infected mast cells recruit NK cells in an CXCL8-
dependent manner [21]. Additional studies have also indicated
that polyI:C inhibits mast cell attachment to adhesion factors
fibronectin and vitronectin [16].
The mechanisms by which dengue virus is detected by the
innate immune system have begun to be investigated. Recently, St.
John et al. demonstrated upregulation of retinoic acid inducible
gene (RIG)-I and melanoma differentiation-associated protein
(MDA)5 mRNA after dengue virus infection in a rodent mast cell
line [22]. However, their model did not involve antibody-
dependent enhancement, which is crucial for the interpretation
of the role of mast cells in dengue hemorrhagic fever. RIG-I and
MDA5 have also been shown to be important for IFN-b
production in mouse embryonic fibroblasts [23] and possibly in
A549 cells [24,25]. Some evidence also exists to support the
involvement of RIG-I or MDA5 in the induction of CCL5 and
CXC chemokine ligand (CXCL)8 production [26,27]. The
dsRNA-dependent protein kinase (PKR) recognizes dsRNA and
can mediate the inhibition of protein translation in response to
type I IFNs and dengue virus dsRNA [28]. However, the function
of PKR has not been investigated in mast cells. Together, all three
sensors provide a mechanism by which the innate immune system
induces the antiviral response when challenged by dengue virus.
In this study, we investigate human mast cell responses to
antibody-enhanced dengue virus infection and exposure to the
synthetic dsRNA analog (polyI:C). Since the link between the
known virus sensors and subsequent mediator release has not been
well characterized, these experiments will aid in identifying viral
‘‘triggers’’ of mast cell antiviral activity. This knowledge could




Human umbilical cord blood was obtained without informed
consent and the data were analyzed anonymously in accordance
with the Izaac Walton Killam Health Center Research Ethics
Board (certificate number 2808; Halifax, Canada). The require-
ment for consent was specifically waived by the Research Ethics
Board.
Cell culture
Human KU812 cells [29] were maintained in RPMI-1640
medium (Sigma, Oakville, Canada), supplemented with 10% fetal
calf serum (FCS; Wisent, St-Bruno, Canada) and 10 mM HEPES.
HMC-1 cells [30] were maintained in Iscove’s modified
Dulbecco’s medium (Invitrogen, Burlington, Canada), supple-
mented with 10% FCS. All cell lines were passaged two to three
times per week.
Primary human cord blood-derived mast cells (CBMC) were
generated from umbilical cord blood mononuclear cells using a
modification of the method of Saito et al. and characterized as
previously described [31]. Umbilical cord blood was obtained
from subjects undergoing elective caesarean sections with
permission from the Izaac Walton Killam Health Center research
ethics board (Halifax,Canada). Cells were cultured at an initial
concentration of 0.6–1610
6 cells/mL and passaged weekly in
RPMI-1640 medium supplemented with 20% FCS, 100 U/mL of
penicillin, 100 mg/mL of streptomycin, 20% CCL-204 cell
supernatant as a source of interleukin-6, 10
27 M prostaglandin
E2 (Sigma), and 50 to 100 ng/ml of stem cell factor (Peprotech,
Rocky Hill, NJ). For qPCR studies, CBMC cultures were sorted
on a BD FACSAria (BD Biosciences, San Jose, CA) after at least 6
weeks of culture to enrich for high side scatter cells characteristic of
mature mast cells. The sorted cells were returned to culture and
the purity was assessed as described below. The purity of all
cultures used was $95% as assessed by toluidine blue (pH 1.0)
staining of cytocentrifuge preparations and examination of cells for
the presence of multiple metachromatic granules and appropriate
nuclear morphology.
Reagents and conditions
The dsRNA analog polyI:C (Endogen, Thermo Scientific,
Rockford, IL and Calbiochem, San Diego, CA) was used as a virus
analogous stimulus. For transfection with polyI:C, 1 mg/ml was
complexed with Lipofectamine 2000 as per the manufacturer’s
instructions (Invitrogen) and added to cells. Sheep anti-human IFN-
a2b antibody (Endogen) and goat anti-human IFN-b antibody
(R&D systems, Minneapolis, MN) were used at 1 or 10 mg/ml for
blockade. Normal sheep or goat IgG were used as controls.
Dengue virus propagation
Dengue virus, type 2 (strain 16681) [32] was propagated in
African green monkey kidney Vero cell monolayers cultured in
endotoxin-free RPMI-1640 medium (Sigma) supplemented with 1%
FCS.Insomecases,dengueviruswasUV-inactivatedbyexposureto
a germicidal lamp at a distance of 10 cm for 10 minutes.
Sera
For antibody-dependent enhancement assays of dengue virus
infection, a dengue-immune serum pool was prepared by using
nine convalescent-phase sera from patients recovering from a
dengue virus serotype 2 infection. The individual dengue-
convalescent patient sera were obtained from a collection provided
by Dr. Bruce Innis, Armed Forces Research Institute of Medical
Science, Bangkok, Thailand [33].
Infection and stimulation conditions
Prior to infection or stimulation, CBMCs were cultured
overnight in normal culture medium lacking prostaglandin E2.
Aliquots of infectious or UV-inactivated dengue virus were
incubated alone or in the presence of a subneutralizing
(1:10,000) dilution of human dengue-immune serum for 60 min
at 4uC. KU812, HMC-1 cells or CBMCs, were adsorbed with
these inocula at a multiplicity of infection of 2–4 pfu/cell (as
assayed on Vero cells) for 90 min at 4uC. Mock infection was
performed using Vero cell-conditioned RPMI-1640 medium
supplemented with 1% FCS. Unadsorbed virus and antibody
was removed by washing once and cells were incubated in RPMI
1640 containing 1% FCS 37uC for 2, 6, 12, 24 or 48 hours as
indicated. CBMCs were placed at 1610
6 cells/mL while HMC-1
and KU812 cells were incubated at 0.5610
6 cells/mL. In parallel
Mast Cell Responses to Dengue Virus Infection
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with 10 mg/mL polyI:C or with 1 mg/ml polyI:C complexed with
Lipofectamine 2000. Cell-free supernatants were obtained by
centrifugation at 300 g for 10 min and were frozen at 280uC.
siRNA knockdown
KU812 cells (4610
6 cells/construct) were electroporated with
150 nM of siRNA specific for PKR, MDA5, RIG-I or a
nonspecific, control sequence from Dharmacon (Lafayette, CO)
using the Amaxa Nucleofactor Device according to manufacturer’s
instructions (Lonza, Rockland, ME). Two rounds of electropora-
tion were performed 48 hours apart, followed by culture in RPMI
containing 1% FBS. Six hours after the second electroporation,
the cells were either mock treated or were infected with dengue in
the presence of dengue-immune human serum. Knockdown was
confirmed using the mock sample.
Quantitative PCR (qPCR) and qPCR array analyses
Total RNA was isolated using the RNeasy mini kit (Qiagen,
Frederick, MD) with DNase treatment (Qiagen) according to the
manufacturer’s protocol. One mg of total RNA was used for cDNA
synthesis using a first strand cDNA kit (C-03 kit from
SABiosciences/Qiagen) according to the manufacturer’s instruc-
tions. Relative expression of a number of selected cytokine,
chemokine and interferon-related genes, was determined using a
custom human RT
2 Profiler PCR Array (SABiosciences/Qiagen)
with an RT
2 SYBR Green/ROX qPCR Master Mix (SABios-
ciences/Qiagen) on a 7900HT Real-Time PCR system (Applied
Biosystems, Carlsbad, CA). The fold-changes of gene expression,
with GAPDH as internal control, were calculated using PCR array
data analysis software (SABiosciences, Qiagen). For quantitative
analysis of the mRNA expression of PKR, RIG-I, MDA5, CCL4,
CCL8, and CXCL10, qPCR primer pairs for these genes were
purchased from SABiosciences/Qiagen. cDNA was prepared as
described above and qPCR was performed with the GoTaq qPCR
Master Mix (Promega, Madison, WI) using the Stratagene
MX3000P system and software (Stratagene/Agilent Technologies,
Cedar Creek, TX). A PKR product was not successfully amplified
from HMC-1 cDNA so PKR was therefore not included in the
HMC-1 analysis. The Ct values for GAPDH and the genes listed
above were used to calculate the normalized relative mRNA
expression of each gene in virus-treated versus mock-treated
samples according to the Pfaffl method [34].
Chemokine Antibody Array
Chemokine content in supernatants from CBMCs stimulated
with medium or dengue virus in the presence of dengue-immune
sera as described above was analyzed using the human chemokine
antibody array I from RayBiotech (Norcross, GA) according to the
manufacturer’s instructions. To prepare samples, 500 mLo f
supernatant from 2 separate donors were pooled before addition
to the membrane. Membranes were exposed to Fujifilm Super RX
Medical X-ray Film and signal intensity was quantified using
Quantity One Software (Bio-Rad Laboratories, Mississauga,
Canada). After blank subtraction from each spot, the positive
controls were used to normalize individual spots across membranes.
The fold increase in production in response to dengue+antibody/
mediumwasdeterminedand onlythosesignalswhich were changed
by $1.5-fold compared with medium were reported.
Fluorescence-activated cell sorter (FACS) analysis
Cells were harvested at indicated times post-infection, fixed in
4% paraformaldehyde, permeabilized using 0.1% saponin and
stained for intracellular expression of dengue E protein using
monoclonal antibody 1B7 [35] or an immunoglobulin (Ig)G2a
isotype control antibody. A goat anti-mouse Alexa 488 conjugate
(Molecular Probes, San Diego, CA) was employed as a secondary
antibody. Data were obtained using a FACScan flow cytometer
(Becton Dickinson) and analyzed using FCS Express 3 (DeNovo
Software, Los Angeles, CA).
Enzyme-Linked Immunosorbent Assay (ELISA)
An ELISA kit was used according to the manufacturer’s
protocol to detect IFN-b (PBL Biomedical Laboratories, Piscat-
away, NJ). Sandwich ELISAs using commercial matched antibody
pairs were obtained to further detect human IFN-a2b (Endogen),
CCL4 (R&D Systems), CXCL8 (R&D Systems) and CXCL10 (BD
Biosciences). CCL5 was detected by sandwich ELISA using a
rabbit anti-human CCL5 antibody from Endogen with a goat anti-
human secondary antibody from R&D Systems. ELISA plates
were developed using the Invitrogen ELISA amplification system
according to manufacturer’s instructions, and were acquired on a
Biotek Epoch microplate reader (Winooski, VT) and analysed
using SoftMaxPro software (Molecular Devices, Sunnyvale, CA).
Western blot
Cells were harvested at indicated times post-infection, washed in
1XPBS and immediately boiled for 5 min in SDS-containing
loading buffer. Aliquots of 10 mg of total protein from samples
were loaded and separated using 10% SDS-PAGE. Protein was
then transferred to a PVDF membrane by semi-dry transfer. Blots
were blocked in Tris-buffered saline containing 0.1% Tween
20+5% non-fat milk, washed and probed using polyclonal rabbit
anti-human RIG-I (Cell Signaling Technologies, Danvers, CA),
polyclonal goat anti-human MDA5 (Santa Cruz Biotechnology
Inc., Santa Cruz, CA), monoclonal rabbit anti-human phospho-
eIF2a (Ser51) (clone 1a19A11, Cell Signaling Technologies),
rabbit polyclonal mouse anti-human eIF2a (Santa Cruz) and
monoclonal mouse anti-mouse PKR antibodies (clone B10, Santa
Cruz). After incubation with appropriate HRP-conjugated sec-
ondary antibodies, blots were developed with Super Signal West-
Dura extended substrate kit (Pierce, Rockford, IL) and a Kodak
Image Station 4000 mm Pro (Kodak, Rochester, NY).
Statistical Analysis
All data are represented as the mean 6 the standard error of the
mean (SEM), unless otherwise stated. ELISA data were analyzed
by ANOVA and paired one-tailed Student’s t-tests. Data that were
not normally distributed were analyzed by Friedman and
Wilcoxon signed rank tests. Data sets that contained fewer than
6 experiments were analyzed by student’s t-tests after log
transformation. P,0.05 was considered significant.
Results
Mast cells upregulate multiple anti-viral signaling
molecules, mediators and receptors in response to
antibody-enhanced dengue virus infection
To more fully elucidate mast cell interactions with dengue virus,
we used a qPCR array to broadly evaluate the genes upregulated
by primary human CBMCs in response to antibody-enhanced
dengue virus infection. The mRNA for several innate receptors
was increased following dengue virus plus dengue-immune sera
treatment, including PKR, RIG-I, MDA5, TLR3 and TLR7
(Table 1). Numerous mediator mRNAs were also upregulated
such as type I IFNs and the chemokines CCL2, CCL3, CCL4,
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transcription of myxovirus resistance (MX)1, 29-59-oligoadenylate
synthetase (OAS)1, OAS2, Myeloid differentiation primary
response gene (MyD)88, NFKB1 and IRF7 was augmented.
These responses were selective, as the quantity of mRNAs such as
TLR8, IFN-abR (IFNAR)1, IFNAR2, Jun, IRF3 and CCL11 did
not change. Little change occurred when CBMCs were treated
with UV-inactivated dengue virus in the presence of dengue-
immune sera indicating that virus replication is necessary and that
mere virus-antibody-receptor interaction is not sufficient to induce
the observed responses.
In order to study the changes in gene expression observed in the
PCR array analysis in more detail, we performed qPCR analysis of
the RNA sensors PKR, RIG-I, and MDA5 in addition to the
chemokines CCL4, CCL8, and CXCL10. Multiple dengue virus
infected CBMCs cultures in addition to the human mast cell lines
KU812 and HMC-1 were analyzed. Similar to the results from the
CBMC PCR array, gene induction in mast cells was dependent on
viral replication (Figure 1A). In addition, the gene induction was
largely dependent on the antibody-mediated enhancement of
infection. Dengue virus alone did induce consistent upregulation of
CXCL10 in KU812 cells, but this level was still greater than
20,000-fold less than the over one million-fold increase in
CXCL10 mRNA after infection with dengue virus in the presence
of antibody (Figure 1A). Interestingly, gene induction in HMC-1
cells was more modest relative to KU812, reaching a maximum
increase of 22-fold for CCL4. A kinetic analysis of gene induction
in three independent CBMC cultures showed a consistent, early,
and prolonged upregulation of the RNA sensor and chemokine
genes in response to antibody-enhanced dengue virus infection
(Figure 1B). The fold transcriptional increase observed in infected
CBMCs (ranging from approximately 20 for PKR to 250,000 for
CXCL10) was similar to the increases seen in infected KU812
cells. In contrast to infected CBMCs, infected KU812 and HMC-1
cells showed little gene upregulation at 12 hours but revealed
strong increases at 18 and 24 hours (Figure 1B).
To confirm protein production of chemokines, supernatants
from CBMCs infected with antibody-enhanced dengue virus or
mock treatment were analyzed using a chemokine antibody array.
Similar to the data presented in Table 1, the production of
chemokines including CCL2, CCL3, CCL4, CCL8, CXCL8 and
CXCL10 was selectively augmented after antibody-enhanced
dengue infection compared with mock treatment (Figure 2 and
Table S1). These data suggest that antibody-enhanced dengue
virus-infected mast cells adopt an anti-viral phenotype that enables
enhanced sensing and responsiveness to the invading virus.
Mast cell production of chemokines is confirmed by
ELISA
To confirm our protein array findings, the production of
chemokines by primary human CBMCs, HMC-1 and KU812
cells after antibody-enhanced dengue virus infection was evaluated
by ELISA. PolyI:C was used as a surrogate viral RNA analog and
was applied either exogenously or by transfection with Lipofecta-
mine 2000. It was found that for CBMCs, polyI:C and antibody-
enhanced dengue virus infection were able to induce significant
levels of CCL4, CCL5 and CXCL10 (Figure 3). Transfected
polyI:C was a more potent inducer of chemokine production than
polyI:C applied exogenously. However, antibody-enhanced den-
gue virus infection induced the highest levels of chemokine
compared with all other stimuli tested. CBMCs also produced 212
or 359 pg/mL of CXCL8 following transfection with polyI:C
Table 1. qPCR arrays reveal upregulation of anti-viral signaling molecules, receptors and mediators in dengue virus-infected
CBMCs.
Gene Fold-increase in mRNA expression/mock Gene Fold-increase in mRNA expression/mock
Dengue+Ab UV-Dengue+Ab Dengue+Ab UV-Dengue+Ab
PKR 11.3 1.3 IRF7 14.1 1.4
OAS1 108.0 2.8 IRF9 5.9 1.4
OAS2 243.2 4.8 IFNAR1 1.0 1.0
MDA5 25.3 1.3 IFNAR2 0.8 1.2
RIG-I 22.6 1.0 IFNA4 36.7 0.7
LGP2 17.4 1.8 IFNA2 303.4 0.3
IPS-1 1.0 1.0 IFNB1 366.1 1.2
TLR3 24.1 1.2 MX1 648.7 9.4
TLR7 3.8 1.0 CCL2 9.7 2.2
TLR8 1.0 1.0 CCL3 27.4 2.4
TICAM1 2.1 1.1 CCL4 78.5 2.8
MYD88 4.0 1.1 CCL5 76.4 1.2
TOLLIP 1.1 1.0 CCL8 9886.9 11.4
NFKB1 2.3 1.1 CCL11 0.7 0.6
NFKB2 1.1 0.8 CCL17 1.2 0.9
JUN 0.9 1.3 CCL24 0.6 1.8
IRF1 2.5 1.0 CXCL8 3.4 1.9
IRF3 1.0 1.0 CXCL10 93347.6 43.0
Bold numbers indicate $2-fold higher levels of mRNA for the respective gene.
LGP2, laboratory of genetics and physiology 2; IPS-1, IFN-b promoter stimulator-1; TICAM1, Toll-like receptor adaptor molecule; TOLLIP, Toll interacting protein.
doi:10.1371/journal.pone.0034055.t001
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(P=0.0073), respectively (n=4–6).
Compared to CBMCs, HMC-1 cells responded to polyI:C with a
similar CCL4, CCL5 and CXCL10chemokineprofile butat higher
levels (Figure 3). In contrast, KU812 cells did not respond to either
extracellular or lipid-transfected polyI:C (Figure 3). However, like
HMC-1 cells, KU812 cells did produce CCL4, CCL5 and
CXCL10 in response to antibody-enhanced dengue virus infection
(Figure 3). Neither HMC-1 nor KU812 cells produced CXCL8 in
response to any of the stimuli tested (n=4–5).
Time course analysis reveals that antibody-enhanced
dengue virus infection results in the rapid CCL4 and
CXCL10 production by CBMCs
To examine the kinetics of chemokine production, CBMCs,
HMC-1 and KU812 cells were infected for various times with
dengue virus inthe presence of dengue-immune sera and chemokine
production was measured by ELISA. CBMC production of CCL4
and CXCL10 was near maximum at 12 hours and was still detected
at 48 hours post-infection (Figure 4). CCL5 was produced more
slowly and peaked at 24 hours. In contrast, but in agreement with
the kinetics of chemokine mRNA induction (Figure 1), HMC-1 and
KU812 cells produced CCL4, CCL5 and CXCL10 more gradually
than CBMCs, with significant differences observed between 12 and
24 hours for all KU812 responses and CXCL10 production by
HMC-1 cells. These data suggest a rapid chemokine response of
human mast cells to antibody-enhanced dengue virus infection.
Antibody-enhanced dengue virus infection and polyI:C
exposure upregulates multiple RNA sensors in mast cells
CBMCs, HMC-1 and KU812 cell lines were investigated for
expression of the RNA sensors RIG-I and MDA5 following
Figure 1. Quantitative PCR analyses of selected genes in
response to antibody-enhanced dengue virus infection. A)
KU812 and HMC-1 cells were exposed to infectious (Den+Ab) or UV-
inactivated dengue virus (UV-Den+Ab) with a subneutralizing concen-
tration of dengue-immune sera (1:10,000). The cells were also exposed
to dengue virus alone (Den) or were mock treated. At 18 hours post-
infection RNA was prepared and qPCR was performed to analyze the
mRNA levels of the indicated genes. After normalizing for the levels of
GAPDH mRNA, the fold increases of the expression of RNA sensor and
chemokine in virus-exposed cells relative to mock treated cells were
calculated. Similar results were obtained at 24 hours post infection (not
shown). Graphs show the mean 6 SEM for KU812 (n=3) and the mean
6 SD for HMC-1 (n=2). B) CBMCs, KU812, and HMC-1 cells were
exposed to infectious dengue virus with a subneutralizing concentra-
tion of dengue-immune sera (1:10,000) or were mock treated. At 12, 18,
and 24 hours post-infection RNA was prepared and qPCR was
performed to analyze the mRNA levels of the indicated genes. After
normalizing for the levels of GAPDH mRNA, the fold increases in
antibody-enhanced dengue-virus infected cells relative to mock treated
cells were calculated. Graphs show the mean 6 SEM for CBMC (n=3
independent cultures) and KU812 (n=3), in addition to the mean 6 SD
for HMC-1 (n=2).
doi:10.1371/journal.pone.0034055.g001
Figure 2. Antibody arrays reveal that CBMCs produce multiple
chemokines in response to antibody-enhanced dengue virus
infection. CBMCs were infected with dengue virus in the presence of a
subneutralizing concentration of dengue-immune sera (1:10,000) or
were mock treated for 24 h, and the cell-free supernatants were
analyzed for chemokine content using a chemokine antibody array. The
most dramatically upregulated chemokines are indicated by numbered
boxes. Results were obtained from two individual CBMC supernatants
that were pooled prior to incorporation in the antibody array.
doi:10.1371/journal.pone.0034055.g002
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enhanced dengue virus infection (Figure 5). Upregulation of both
RIG-I and MDA5 occurred in CBMCs in response to both
transfected polyI:C and antibody-enhanced dengue virus infection
at 12 hours post-infection, with some upregulation in response to
extracellular polyI:C. Greater increases of RIG-I and MDA5 were
observed by 24 hours post-infection. Upregulation of RIG-I and
MDA5 protein levels in HMC-1 cells by extracellular and
transfected polyI:C and antibody-enhanced dengue virus infection
occurred, but with increased levels at the earlier 12 hour time-
point, compared to CBMCs. Finally, while KU812 cells
upregulated both RIG-I and MDA5 in response to antibody-
enhanced dengue virus infection, neither extracellular nor
transfected polyI:C had any effect on expression in these cells.
We investigated whether the well-known dsRNA receptor/
kinase PKR was involved in the detection of polyI:C and dengue
virus by CBMCs by employing western blot for total PKR protein
and phosphorylation of the PKR substrate eukaryotic initiation
factor (eIF)2a, indicative of PKR activation [36]. It was found that
total PKR protein expression was increased at 12 hours in
CBMCs following transfection with polyI:C or antibody-enhanced
dengue virus infection (Figure 5). By 24 h, total PKR expression
was further increased in these groups; in addition, an increase in
response to extracellular polyI:C occurred. Phosphorylation of the
host translation initiation factor eIF2a, which causes inhibition of
host translation, occurred in response to extracellular and
transfected polyI:C and antibody-enhanced dengue virus infection
at both 12 and 24 h. Total eIF2a protein was unaffected. In
contrast, HMC-1 and KU812 cells did not show the same
upregulation of PKR and phosphorylated eIF2a.
siRNA mediated knockdown of RNA sensors alters
responses of KU812 cells to antibody-enhanced dengue
virus infection
KU812 cells were used to investigate modulation of responses to
antibody-enhanced dengue virus infection following siRNA
mediated knockdown of the RNA sensors PKR, RIG-I and
MDA5 (Figure 6). Knockdown of RIG-I led to a significant
decrease in the amount of CCL4 and CCL5 chemokine
production. In contrast, knockdown of PKR resulted in increased
chemokine release, presumably due to the removal of eIF2a-
mediated translational inhibition. Taken together, this suggests
that RIG-I and PKR act as positive and negative regulators,
respectively, of chemokine synthesis induced in response to
antibody-enhanced dengue virus infection.
Human mast cells infected with dengue virus secrete
type I interferons that can potently suppress subsequent
dengue virus infection
Since our initial mRNA array data clearly indicated an
upregulation of mRNA for the anti-viral type I interferons in
CBMC after antibody-enhanced dengue virus infection (Table 1),
we examined mast cell type I IFN production and function in
more detail. After 24 hours, CBMCs produced significant levels of
IFN-a2b in response to transfected polyI:C and antibody-
Figure 3. ELISA confirms CBMC antiviral chemokine release following antibody-enhanced dengue virus infection or polyI:C
exposure. CBMCs, HMC-1 and KU812 cells were infected with dengue virus in the presence of a subneutralizing concentration (1:10,000) of dengue-
immune sera (DEN+Ab) or were exposed to 10 mg/mL polyI:C (pI:C (10)) or 1 mg/ml polyI:C complexed to Lipofectamine 2000 (pI:C (1)+Lpf). Controls
included mock treatment, dengue virus only (DEN) and UV-inactivated dengue virus with dengue-immune sera (UV-DEN+Ab). After 24 hours, cell
supernatants were harvested and measured for CCL4, CCL5 and CXCL10 by ELISA. Graphs show the mean 6 SEM of 7–16 separate experiments.
*P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0034055.g003
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not shown). In contrast, HMC-1 and KU812 cells produced IFN-
b only when infected with dengue virus (Figure 7A), and no
detectable IFN-a2b. Time course analysis revealed that type I IFN
production occurred gradually, with peak production observed at
24 to 48 hours (Figure 7B).
To examine the potential antiviral protective effects of the
detected mediators, especially CXCL10 [37,38] and type I IFNs,
48 h post-infection supernatants from mock- or variously treated
CBMCs were added to fresh, uninfected target KU812 cells.
Following incubation for 24 hours, the KU812 cells were then
exposed to dengue virus in the presence of subneutralizing human
dengue-immune serum. At 24 hours post-infection cells were
analyzed for dengue envelope (E) protein by flow cytometry
(Figure 7C). KU812 cells pretreated with supernatants from
previously infected CBMCs were completely protected from
antibody-enhanced dengue virus infection. In contrast, no protec-
tion was observed using supernatants from CBMCs which were
mock-treated or treated with UV-inactivated dengue virus in the
presence of dengue-immune sera. Neutralization of IFN-a2b using
an IFN-a2b-specific antibody eliminated the supernatant-mediated
protection of target KU812 cells from antibody-enhanced dengue
virus infected CBMCs. This inhibitory effect was not observed with
anti-IFN-b or control antibodies. Similar protective results were
observed with HMC-1 and KU812 cell supernatants, and this was
attenuated by addition of an IFN-b-specific antibody (data not
shown). This implicates type I IFN as a major protective factor for
viral infection produced by dengue virus-infected mast cells.
Discussion
In this study we examined gene expression by primary human
mast cells (CBMCs) and mast cell lines (HMC-1 and KU812)
infected with antibody-enhanced dengue virus, and discovered that
many key anti-viral receptors and mediators are upregulated during
infection. We also showed that CBMCs, HMC-1 cells, and KU812
cells produce CCL4, CCL5, CXCL10 and type I IFNs when
infected with dengue virus or stimulated with the dsRNA analogue
polyI:C. Importantly, chemokine production by CBMCs occurred
early in dengue virus infection. Mast cells increased expression of
the RNA sensors RIG-I, MDA5 and PKR upon dengue virus
infection or polyI:C exposure, and phosphorylation of the PKR
substrate eIF2a indicated activation of the receptor. Moreover,
siRNA-mediated knockdown of PKR, RIG-I and MDA5 demon-
strated opposing roles for RIG-I and PKR in the regulation of
chemokine production. Finally, mast cell supernatants were able to
prevent infection of target KU812 cells, a process which was
dependent on mast cell production of type I IFNs.
Interestingly, CBMCs produced only IFN-a at the protein level,
whereas dendritic cells are known to produce both IFN-a and
IFN-b when stimulated with polyI:C [39]. Selective mast cell
production of IFN-a in the absence of IFN-b has also been
confirmed in polyI:C-stimulated peripheral blood-derived mast
cells [13]. Since the signaling pathways induced by polyI:C in
dendritic cells are different from those triggered in endothelial cells
and fibroblasts [40], it is possible that signaling in human mast
cells and dendritic cells may also be distinct. The absence of
Figure 4. Time course analysis reveals rapid production of CCL4 and CXCL10 by antibody-enhanced dengue virus-infected CBMCs.
CBMCs, HMC-1 and KU812 cells were infected with dengue virus with a subneutralizing concentration (1:10,000) of dengue-immune sera
(Dengue+Ab) for 12, 24, or 48 hours. Controls included mock treatment, dengue virus only (Dengue) and UV-inactivated dengue virus with dengue-
immune sera (UV-Dengue+Ab). Cell supernatants were harvested and measured for CCL4, CCL5 and CXCL10 by ELISA. Graphs show the mean 6 SEM
of 3–16 separate experiments. *P,0.05; **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0034055.g004
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resting dendritic cells do express this RNA sensor [41].
The expression of the cytosolic RNA receptors PKR, RIG-I,
and MDA5 were found to all be increased in response to polyI:C
and antibody-enhanced dengue virus infection. St. John et al. have
also demonstrated increased expression of MDA5 and RIG-I in
dengue virus infected mast cells in a rodent model that did not
include antibody-dependent enhancement [22]. However, we did
not observe increased expression with dengue virus alone (Figures 2
and 5), suggesting that the sensitivity of mast cells to dengue virus
may vary by species. Our data showing the importance of RIG-I
and PKR in regulating mast cell chemokine production advances
our current understanding of RNA sensor function in mast cell
responses to viral infection (Figure 6).
Our findings provide the first demonstration that mast cells can
produce sufficient amounts of type I IFNs to protect neighbouring
cells from infection. The induction of an anti-viral state by type I
IFNs is a well-known initial response to viral infection [42]. Type I
Figure5.Mast cells upregulate RNAsensorsfollowing antibody-
enhanced dengue virus infection and polyI:C exposure. CBMCs,
HMC-1 and KU812 cells were exposed to infectious (Den+Ab) or UV-
inactivated dengue virus (UV-Den+Ab) with a subneutralizing concen-
tration of dengue-immune sera (1:10,000), 10 mg/ml polyI:C (pI:C (10)) or
1 mg/ml polyI:C transfected with Lipofectamine 2000 (pI:C (1)+Lpf). As
controls, CBMCswere exposed todenguevirusalone(Den)or were mock
treated. At 12 and 24 hours post-infection cell lysates were prepared. A
total of 10 mg of each lysate was resolved on a 10% SDS-PAGE and semi-
dry transferred to PVDF and probed for RIG-I, MDA5, PKR, eIF2a and
phospho-eIF2a,a sw e l la sb-actin as loading control. Data are
representative of at least three separate experiments.
doi:10.1371/journal.pone.0034055.g005
Figure 6. siRNA mediated knockdown of RNA sensors modu-
lates KU812 responses to antibody-enhanced dengue virus
infection. Following knockdown of the indicated genes by siRNA
transfection, KU812 cells were mock treated or exposed to infectious
dengue virus with subneutralizing concentration of dengue-immune
sera (1:10,000). At 24 hours post-infection supernatants were harvested
and analyzed for CCL4, CCL5 and CXCL10 content by ELISA. Graphs
show the mean 6 SEM of 4 separate experiments. ns, not significant;
*P,0.05; **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0034055.g006
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e34055Figure 7. Type I interferons secreted by dengue virus-infected CBMCs suppress dengue virus infection of target cells. (A) CBMCs,
HMC-1 and KU812 cells were infected with infectious (DEN+Ab) or UV-inactivated (UV-DEN+Ab) dengue virus in the presence of a subneutralizing
concentration of dengue-immune sera (1:10,000) or were exposed to 10 mg/mL polyI:C (pI:C (10)) or 1 mg/ml polyI:C complexed to Lipofectamine
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MDA5 expression along with a number of other important
interferon stimulated genes [43,44,45]. The upregulation of RNA
sensors such as RIG-I and MDA5 appears to be key for the
suppression of dengue virus replication [25,46,47]. The possibility
that tissue-resident mast cells can initiate this vital response places
them in a position to protect neighbouring cells at the tissue site
rapidly after inoculation. The establishment of an antiviral state
also supports our findings that PKR is activated in mast cells upon
dengue virus infection, as protein translation inhibition during
virus infection is dependent on the PKR substrate, eIF2a [28].
Circulating levels of CCL4 and CCL5 in dengue patients are
positively correlated with good prognosis [14,15]. This may be
explained by their chemoattractant function for T cells and NK
cells, both of which are important for viral clearance. Additionally,
in mouse models of dengue infection, CXCL10 is crucial for CD8
+
T cell and NK cell infiltration to sites of viral replication. Mice
lacking the CXCL10 receptor CXCR3 have increased mortality
rates compared to wild type [37,38]. High concentrations of
CXCL10 have also been shown to inhibit dengue virus entry by
competing for heparin sulfate binding [37]. Conversely, CXCL8
and CXCL10 appear to be an indicator of increased disease
severity and patient death [48,49], of which the former may be
due to CXCL8-induced vascular permeability [50]. These studies
suggest that mast cell production of CCL4, CCL5 and CXCL10
may be beneficial in the immunity to dengue virus, however more
studies will be required to understand the overall effects of mast
cell responses in dengue virus infection.
The ability to respond to polyI:C, either extracellular or
cytosolic, varied among the mast cells examined. While HMC-1
cells responded to both extracellular and transfected polyI:C,
CBMCs responded mainly to transfected polyI:C, and KU812
cells were unresponsive to both. However, antibody-enhanced
dengue virus infection was able to stimulate mediator release and
RNA sensor upregulation in all three types of mast cells. These
results most likely reflect a varied RNA sensor repertoire between
different mast cells. The endosomal RNA sensors TLR3, TLR7 or
TLR8 may participate in the detection of extracellular polyI:C
and dengue virus. TLR3 may be important for the detection of
dengue virus by certain cell types, including monocytic cell types
[51]. Human peripheral blood-derived mast cells and the HMC-1
mast cell line have previously been shown to respond to
extracellular polyI:C resulting in type I IFN production via
TLR3 [13]. However, TLR3 protein expression and function in
CBMCs and KU812 cells, remains to be determined.
The inability of KU812 cells to respond to transfected polyI:C is
a curious finding, since KU812 cells are able to express PKR,
RIG-I and MDA5, with PKR occurring at high constitutive levels
(Figure 5). One consideration may be the preparation of polyI:C
used for these studies. While PKR is reported to bind dsRNA
greater than 30 nucleotides, the requirements for recognition of
polyI:C by MDA5 and RIG-I remain controversial. RIG-I binds
to 59-triphosphorylated RNA and dsRNA shorter than 1 Kb,
while MDA5 binds dsRNA longer than 2 kb [52]. Our source of
polyI:C is reported by the manufacturer (Endogen) to range
between 2–3 kb. Future studies examining a range of verified
polyI:C lengths, in vitro transcribed RNA and those with 59-
triphosphates may provide insight into the responsiveness of mast
cells to various virus analogous stimuli.
The early detection of invading pathogens is critical in
preventing more serious manifestations of disease [53]. Time
course analysis revealed that primary human CBMCs accumulate
maximal levels of CCL4 and CXCL10 mRNA and produce
CCL4 and CXCL10 in nanogram amounts as early as 12 hours
post-infection (Figures 1, 3, and 4). Few studies have demonstrated
chemokine production this early in infection. While monocyte-
derived dendritic cells can produce large amounts of CCL4 [54]
and CXCL10 [55] in response to dengue virus, they are not
resident in the dermis as mast cells are, and would not be activated
immediately upon dengue virus infection. Therefore, mast cells are
likely key responders in the detection and mobilization of the
immune system during the early stages of dengue virus infection.
Our data support a role for mast cells in the protection of
neighbouring cells through type I IFN production. Furthermore,
human mast cell-derived chemokines may recruit key effector cells
suchasNKcellsandTcellstothesiteofinfection.Insupportofthis,
a recent in vivo study using a mouse model of infection demonstrated
that mast cells are important for NK cell and NK1.1
+ T cell
recruitment to dengue virus infection sites [22]. It should be noted
however that mast cell production of mediators such as CCL4 may
also attract macrophages, which are primary targets of dengue virus
infection. Further studies focusing on the impact of mast cell
mediators on surrounding cell populations during dengue virus
infection will provide insight into the true impact of their responses.
This report is the first study demonstrating an important role for
RNA sensors, particularly RIG-I and PKR, in human mast cell
cytokine/chemokine responses to dengue virus. Mast cells are
tissue-resident granulocytes with the ability to selectively produce
profiles of mediators, and are likely first responders in infection.
These findings broaden our knowledge of mast cell responses to
dengue virus and virus infection in general and provide strong
support for the role of mast cells as innate sensors of pathogen
invasion.
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2000 (pI:C (1)+Lpf). Controls included mock treatment and dengue virus only (DEN). After 24 hours, cell supernatants were harvested and assayed for
IFN-a2b and IFN-b by ELISA. Graphs show the mean 6 SEM of 4–9 separate experiments. (B) CBMCs, HMC-1 and KU812 cells were treated as in (A).
After 12, 24 and 48 hours supernatants were analyzed for IFN-a2b and IFN-b content by ELISA. Graphs show the mean 6 SEM of 3–9 separate
experiments. (C) CBMCs were infected with dengue virus as described in (A). (C) 48 hour supernatants from CBMCs treated as in (A) were added
directly or were blocked for 1 hour on ice with 10 mg/ml sheep anti-human IFN-a2b, goat anti-human IFN-b or appropriate control IgG, prior to
addition to fresh KU812 target cells for 24 hours. Cells were then infected with dengue virus with a 1:10,000 dilution of dengue- immune sera. At
24 hours post-infection KU812 cells were harvested, fixed and permeabilized for detection of intracellular dengue virus E protein by FACS. Data are
representative of at least three separate experiments. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0034055.g007
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